DK1165558T3 - Pyrimido[6,1-a]isoquinolin-4-on-derivater - Google Patents

Pyrimido[6,1-a]isoquinolin-4-on-derivater

Info

Publication number
DK1165558T3
DK1165558T3 DK00920857T DK00920857T DK1165558T3 DK 1165558 T3 DK1165558 T3 DK 1165558T3 DK 00920857 T DK00920857 T DK 00920857T DK 00920857 T DK00920857 T DK 00920857T DK 1165558 T3 DK1165558 T3 DK 1165558T3
Authority
DK
Denmark
Prior art keywords
pyrimido
isoquinolin
derivatives
relates
isoenzymes
Prior art date
Application number
DK00920857T
Other languages
English (en)
Inventor
Alexander William Oxford
David Jack
Original Assignee
Vernalis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9907454.4A external-priority patent/GB9907454D0/en
Priority claimed from GBGB9909802.2A external-priority patent/GB9909802D0/en
Application filed by Vernalis Ltd filed Critical Vernalis Ltd
Application granted granted Critical
Publication of DK1165558T3 publication Critical patent/DK1165558T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
DK00920857T 1999-03-31 2000-03-29 Pyrimido[6,1-a]isoquinolin-4-on-derivater DK1165558T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9907454.4A GB9907454D0 (en) 1999-03-31 1999-03-31 Compounds
GBGB9909802.2A GB9909802D0 (en) 1999-04-28 1999-04-28 Compounds
PCT/GB2000/001193 WO2000058308A1 (en) 1999-03-31 2000-03-29 DERIVATIVES OF PYRIMIDO[6,1-a]ISOQUINOLIN-4-ONE

Publications (1)

Publication Number Publication Date
DK1165558T3 true DK1165558T3 (da) 2004-02-09

Family

ID=26315369

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00920857T DK1165558T3 (da) 1999-03-31 2000-03-29 Pyrimido[6,1-a]isoquinolin-4-on-derivater

Country Status (16)

Country Link
US (5) US6794391B2 (da)
EP (1) EP1165558B1 (da)
JP (1) JP4685243B2 (da)
CN (1) CN100415743C (da)
AT (1) ATE250602T1 (da)
AU (1) AU773504B2 (da)
BR (1) BRPI0009446B8 (da)
CA (1) CA2368413C (da)
DE (1) DE60005493T2 (da)
DK (1) DK1165558T3 (da)
ES (1) ES2208310T3 (da)
MX (1) MXPA01009846A (da)
NO (1) NO20014728L (da)
NZ (1) NZ514158A (da)
PT (1) PT1165558E (da)
WO (1) WO2000058308A1 (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100415743C (zh) * 1999-03-31 2008-09-03 韦尔纳利斯有限公司 嘧啶并[6,1-a] 异喹啉-4-酮衍生物
EP1898894A1 (en) * 2005-06-17 2008-03-19 Boehringer Ingelheim International GmbH Mrp iv inhibitors for the treatment of respiratory diseases
EP2138495A1 (en) * 2008-06-26 2009-12-30 sanofi-aventis Substituted pyrimido[2,1-a]isoquinolin-4-one derivatives
AR082601A1 (es) * 2010-08-09 2012-12-19 Verona Pharma Plc Formas cristalinas de compuestos de pirimido[6,1-a]isoquinolin-4-ona
US8883857B2 (en) 2012-12-07 2014-11-11 Baylor College Of Medicine Small molecule xanthine oxidase inhibitors and methods of use
SI2968313T1 (en) 2013-03-15 2018-05-31 Verona Pharma Plc Combination of medicines
EP3142701B1 (en) * 2014-05-12 2018-06-27 Verona Pharma PLC New treatment
LT3193835T (lt) * 2014-09-15 2018-06-11 Verona Pharma Plc Skysta inhaliuojama vaisto forma, apimanti rpl554
GB201502260D0 (en) * 2015-02-11 2015-04-01 Verona Pharma Plc Salt of Pyrimido[6,1-A]Isoquinolin-4-one compound
GB201613054D0 (en) 2016-07-28 2016-09-14 Verona Pharma Plc New compound and process
IL280075B2 (en) 2018-07-13 2024-06-01 Chia Tai Tianqing Pharmaceutical Group Co Ltd A conjugated tricyclic compound as a dual PDE3/PDE4 inhibitor
GB2578093B (en) 2018-10-09 2020-11-18 Verona Pharma Plc Liquid pharmaceutical composition comprising RPL554 and HFA-134A
GB201911517D0 (en) 2019-08-12 2019-09-25 Verona Pharma Plc Pharmaceutical composition
AU2021208129A1 (en) * 2020-01-15 2022-08-18 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Pharmaceutical composition of tricyclic PDE3/PDE4 dual inhibitor compound
JP2023512471A (ja) * 2020-01-15 2023-03-27 チア タイ ティエンチン ファーマシューティカル グループ カンパニー リミテッド Ｐｄｅ３／ｐｄｅ４二重阻害剤の結晶及びその使用
GB202002786D0 (en) 2020-02-27 2020-04-15 Verona Pharma Plc Liquid pharmaceutical composition
GB2594480A (en) * 2020-04-28 2021-11-03 Verona Pharma Plc New treatment
JP2024517583A (ja) * 2021-04-29 2024-04-23 ▲蘇▼州盛迪▲亞▼生物医▲薬▼有限公司 イソキノリノン系化合物及びその用途
WO2023076205A1 (en) 2021-10-29 2023-05-04 Teva Pharmaceuticals International Gmbh Solid state forms of ensifentrine and process for preparation thereof
EP4450500A1 (en) * 2021-12-14 2024-10-23 Xizang Haisco Pharmaceutical Co., Ltd. Tricyclic fused heterocyclic pde3/4 dual inhibitor and use thereof
WO2023138676A1 (zh) * 2022-01-21 2023-07-27 四川海思科制药有限公司 三环稠杂环类pde3/4双重抑制及其用途
GB202202297D0 (en) 2022-02-21 2022-04-06 Verona Pharma Plc Formulation production process
WO2024033625A1 (en) 2022-08-08 2024-02-15 Verona Pharma Plc Ensifentrine (rpl-554) for increasing trough lung function
WO2024033627A1 (en) 2022-08-08 2024-02-15 Verona Pharma Plc Liquid pharmaceutical composition
WO2024084212A1 (en) 2022-10-20 2024-04-25 Verona Pharma Plc Treatment of idiopatic pulmonary fibrosis with ensifentrine
WO2024088402A1 (zh) * 2022-10-28 2024-05-02 江苏恒瑞医药股份有限公司 一种异喹啉酮类化合物的晶型及其制备方法
EP4378942A1 (en) 2022-12-02 2024-06-05 Sandoz AG Crystal form of a pde3/4 inhibitor
WO2024127413A1 (en) * 2022-12-14 2024-06-20 Cipla Limited Solid state forms of ensifentrine

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ185900A (en) * 1976-12-10 1981-04-24 Hoechst Ag Pyrimido (6,1-a) isoquinolin-4-ones medicaments intermediate isoquinolines
FI64370C (fi) * 1977-05-05 1983-11-10 Hoechst Ag Foerfarande foer framstaellning av terapeutiskt anvaendbara pyimido-(6,1-a)isokinolin-2-imino-4-onderivat
DE2847693A1 (de) * 1978-11-03 1980-05-22 Hoechst Ag Verfahren zur herstellung von pyrimido-(6,1-a)-isochinolin-2-onen
US4254121A (en) * 1979-08-13 1981-03-03 Ayerst, Mckenna & Harrison Inc. 3-Oxo-5H-pyrimido[2,1-c][1,4 ]benzoxazines
US4307092A (en) * 1979-08-13 1981-12-22 Ayerst Mckenna & Harrison, Inc. 1-Oxo-5H-pyrimido[2,1-C]benzoxazine-2-carboxylic acid esters
US4254118A (en) * 1979-08-13 1981-03-03 Ayerst, Mckenna & Harrison Inc. 1-Oxo-5H-pyrimido[2,1-c][1,4]benzthiazine-2-carboxylic acid esters
CA1237429A (en) * 1983-05-05 1988-05-31 Frank Kienzle Pyrimidone derivatives
NZ227850A (en) * 1988-02-10 1991-11-26 Hoffmann La Roche Indole substituted pyrrole derivatives; preparatory process and medicaments for use against inflammatory immunological, bronchopulmonary or vascular disorders
DE3816995A1 (de) * 1988-05-19 1989-11-23 Hoechst Ag Verwendung von pyrimido-(6,1-a)-isochinolin-4-on-derivaten und medizinische zubereitungen auf basis dieser verbindungen
US5728705A (en) * 1993-10-04 1998-03-17 The Trustees Of Columbia University In The City Of New York Method of inducing vasorelaxation to treat pulmonary hypertension
DE4430128A1 (de) * 1994-08-25 1996-02-29 Hoechst Ag Kombinationspräparat mit immunsuppressiven, kardiovaskulären und cerebralen Wirkungen
US5665737B1 (en) * 1994-10-12 1999-02-16 Euro Celtique Sa Substituted benzoxazoles
JPH10287655A (ja) * 1997-04-10 1998-10-27 Kaken Pharmaceut Co Ltd ピラゾール誘導体
CN100415743C (zh) * 1999-03-31 2008-09-03 韦尔纳利斯有限公司 嘧啶并[6,1-a] 异喹啉-4-酮衍生物

Also Published As

Publication number Publication date
BRPI0009446B8 (pt) 2021-05-25
DE60005493T2 (de) 2004-07-01
BR0009446A (pt) 2002-01-15
EP1165558B1 (en) 2003-09-24
US20040176353A1 (en) 2004-09-09
US20120302533A1 (en) 2012-11-29
US7105663B2 (en) 2006-09-12
US20030036542A1 (en) 2003-02-20
US20080206163A1 (en) 2008-08-28
EP1165558A1 (en) 2002-01-02
US7378424B2 (en) 2008-05-27
PT1165558E (pt) 2004-02-27
AU4127400A (en) 2000-10-16
WO2000058308A1 (en) 2000-10-05
NO20014728D0 (no) 2001-09-28
DE60005493D1 (de) 2003-10-30
CA2368413C (en) 2008-07-29
US8242127B2 (en) 2012-08-14
US6794391B2 (en) 2004-09-21
CN100415743C (zh) 2008-09-03
MXPA01009846A (es) 2003-06-24
ATE250602T1 (de) 2003-10-15
JP2002540207A (ja) 2002-11-26
CA2368413A1 (en) 2000-10-05
CN1348453A (zh) 2002-05-08
NZ514158A (en) 2000-03-29
JP4685243B2 (ja) 2011-05-18
NO20014728L (no) 2001-11-23
US20040171828A1 (en) 2004-09-02
BRPI0009446B1 (pt) 2016-11-01
AU773504B2 (en) 2004-05-27
ES2208310T3 (es) 2004-06-16

Similar Documents

Publication Publication Date Title
ATE250602T1 (de) Pyrimido(6,1-a)isochinolinonderivate
BR0108396A (pt) Derivados de pirimidina-4-0na como inibidores de ldl-pla(2)
WO2001049688A8 (en) Purine derivatives, process for their preparation and use thereof
MY133311A (en) Novel imidazopyridines as cyclin dependent kinase inhibitors
DK1537116T3 (da) Pyrazolopyrimidiner egnede til behandling af cancersygdomme
MX9702307A (es) Pirrolo (2,3-d)pirimidinas y su uso.
MY134589A (en) Imidazopyrazines as cyclin dependent kinase inhibitors
TR199800012T1 (xx) Piroloprimidinler ve preparasyon i�in tatbikler.
MXPA04003668A (es) Inhibidores de fosfodiesteresa de tipo 4 y usos de los mismos.
MY139336A (en) N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors
FI945363A (fi) Uusia merkaptoasetyyliamidopyridatso (1,2)pyridatsiini-, pyratsolo(1,2)pyridatsiini-, pyridatso (1,2-a)(1,2)diatsepiini- ja pyratsolo(1,2-a)(1,2)diatsepiinijohdannaisia, jotka ovat käyttökelpoisia enkefalisaasin ja ACE:n estäjinä
MY141978A (en) Pyrazolopyrimidines as cyclin dependent kinase inhibitors
HUP0500163A3 (en) Pyrazolo [5,1-b]quinazoline derivatives and pharmaceutical compositions thereof as inhibitors of impdh enzyme
ATE320436T1 (de) Dimere pyrrolobenzodiazepine
ES2195785A1 (es) Nuevos derivados de piridazin-3(2h)-ona.
MXPA03010961A (es) Compuestos de tiazol utiles como inhibidores de proteinas cinasas.
AU2795000A (en) Epothilone derivatives and their use as antitumor agents
MY145332A (en) Trisubstituted 4-aminopyrazolopyrimidines as cyclin dependent kinase inhibitors
HK1065483A1 (en) 4-amino-6-phenyl-pyrrolo[2,3-d]pyrimidine derivatives
WO1997015555A3 (de) Imidazolderivate und deren verwendung als stickstoffmonoxid-synthase-inhibitoren
MY136840A (en) Pyrazolopyridines as cyclin dependent kinase inhibitors
WO2000040583A3 (de) Imidazo[4,5-c]-pyridin-4-on-derivate
AU2002366736A1 (en) Masked phosphate containing nucleoside derivatives and their use as antivirals
DE60008400D1 (de) Triazolopyrimidinderivate
MY136822A (en) Derivatives of [6, 7-dihydro-5h-imidazo[1,2-a]imidazole-3-sulfonylamino]-propionamide and their use as inhibitors upon the interaction of cams and leukointegrins